Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Falconi

Showing results (541-550 of 557) with videos related to

Pageof 56
Sort By:
JAMA Surgery|November 12, 2025
International Reference Values for Surgical Outcomes of Total PancreatectomyPhilip C Müller, Caroline Berchtold, Christoph Kuemmerli, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction ModelMarco Lanzillotta, Peter Macinga, Jakob L Poulsen, et al.
Science Translational Medicine|July 19, 2019
A multimodality test to guide the management of patients with a pancreatic cystSimeon Springer, David L Masica, Marco Dal Molin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 6, 2024
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to TreatmentKasper A Overbeek, Jakob L Poulsen, Marco Lanzillotta, et al.
Annals of Surgery|November 4, 2017
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched StudyJony van Hilst, Thijs de Rooij, Sjors Klompmaker, et al.
Annals of Surgery|September 5, 2020
Defining Benchmark Outcomes for Pancreatoduodenectomy With Portomesenteric Venous ResectionDimitri A Raptis, Patricia Sánchez-Velázquez, Nikolaos Machairas, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
The Lancet. Oncology|March 5, 2026
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancerCarl-Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, et al.
Annals of Surgery|August 6, 2021
The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter AnalysisNikolaos Machairas, Dimitri A Raptis, Patricia Sánchez Velázquez, et al.
Pageof 56

Showing results (541-550 of 557) with videos related to

Sort By:
Pageof 56
JAMA Surgery|November 12, 2025
International Reference Values for Surgical Outcomes of Total PancreatectomyPhilip C Müller, Caroline Berchtold, Christoph Kuemmerli, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction ModelMarco Lanzillotta, Peter Macinga, Jakob L Poulsen, et al.
Science Translational Medicine|July 19, 2019
A multimodality test to guide the management of patients with a pancreatic cystSimeon Springer, David L Masica, Marco Dal Molin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 6, 2024
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to TreatmentKasper A Overbeek, Jakob L Poulsen, Marco Lanzillotta, et al.
Annals of Surgery|November 4, 2017
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched StudyJony van Hilst, Thijs de Rooij, Sjors Klompmaker, et al.
Annals of Surgery|September 5, 2020
Defining Benchmark Outcomes for Pancreatoduodenectomy With Portomesenteric Venous ResectionDimitri A Raptis, Patricia Sánchez-Velázquez, Nikolaos Machairas, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
The Lancet. Oncology|March 5, 2026
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancerCarl-Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, et al.
Annals of Surgery|August 6, 2021
The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter AnalysisNikolaos Machairas, Dimitri A Raptis, Patricia Sánchez Velázquez, et al.
Pageof 56